A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction

Citation
Awj. Van 'T Hof et al., A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction, EUR HEART J, 20(9), 1999, pp. 659-665
Citations number
17
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
EUROPEAN HEART JOURNAL
ISSN journal
0195668X → ACNP
Volume
20
Issue
9
Year of publication
1999
Pages
659 - 665
Database
ISI
SICI code
0195-668X(199905)20:9<659:ARCOIB>2.0.ZU;2-E
Abstract
Aims Intra-aortic balloon pumping reduces afterload and may be effective in improving reperfusion in high risk infarct patients treated with primary a ngioplasty. Methods High risk infarct patients referred from other centres for primary PTCA were randomized to treatment with or without an intra-aortic balloon p ump. The primary end-point consisted of the combination of death, non-fatal reinfarction, stroke or an ejection fraction <30% at the 6 month follow-up . A weighted unsatisfactory outcome score (as previously described by Braun wald), enzymatic infarct size and left ventricular ejection fraction were s econdary end-points. Results During a 3.5 year period, 238 patients were randomized, 118 to intr a-aortic balloon pump therapy and 120 to no intra-aortic balloon pump thera py. Cross-over (25% in the intra-aortic balloon pump group and 31% in the n o-intra-aortic balloon pump group) occurred in both treatment arms. The pri mary end-point was reached in 31 (26%) patients assigned to an intra-aortic balloon pump and in 31 (26%) assigned to no intra-aortic balloon pump (P=0 .94). Enzymatic infarct size (LDHQ(72)) was calculated in 163 (68%) patient s and was not significantly different between either group (intra-aortic ba lloon pump: 1616 +/- 1148, no intra-aortic balloon pump: 1608 +/- 1163). Th e left ventricular ejection fraction was measured at the 6 month follow-up in 168 patients (80% of patients alive). No difference in ejection fraction was found in either group (intra-aortic balloon pump: 42 +/- 13%, no intra -aortic balloon pump: 40 +/- 14%, P=0.51). Major complications occurred in 8% of patients treated with an intra-aortic balloon pump. Conclusion Systematic use of intra-aortic balloon pumping after primary ang ioplasty does not lead to myocardial salvage or to a better clinical outcom e in high-risk infarct patients. Use of intra-aortic balloon pumping after primary PTCA for acute myocardial infarction should be reserved for patient s with severe haemodynamic compromise.